Results

Total Results: 2,228 records

Showing results for "disease".

  1. Bar-Cohen_ ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/bar-cohen_-eccs2012.pdf
    January 01, 2012 - o Understand what the outcome is (getting disease, dying from  disease, developing  a symptom), … Explain the number of people with the disease, and always include “Out of how many?” … to illustrate the chance of the disease.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
    June 01, 2012 - Patients in the “With Disease” category actually have the disease of interest, and those in the “Healthy … If a patient is in the “With Disease” category and tests positive for the disease using the test of interest … who will test positive for the disease. … Specificity is the proportion of people without disease who test negative for the disease. … of the test being positive in people without a disease.
  3. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
    June 01, 2012 - Patients in the “With Disease” category actually have the disease of interest, and those in the “Healthy … If a patient is in the “With Disease” category and tests positive for the disease using the test of interest … who will test positive for the disease. … Specificity is the proportion of people without disease who test negative for the disease. … of the test being positive in people without a disease.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
    July 01, 2012 - An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and … Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were … How many genes underlie the occurrence of common complex diseases in the population? … Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. … Research priorities for evaluating family history in the prevention of common chronic diseases.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
    August 18, 2011 - chronic disease. … For this reason, and because their longer duration means chronic diseases cause greater disease burden … Among patients with chronic diseases with self-administered medication prescribed by a provider, what … Among patients with chronic diseases with self-administered medication prescribed by a provider, what … Noncommunicable Diseases and Mental Health Cluster.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diverticulitis-research-protocol.pdf
    January 01, 2019 - Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. … Treatment of perforated diverticular disease of the colon. Adv Surg. 1978;12:85-109. … Prevention and Conservative Therapy of Diverticular Disease. … Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review. … Diagnosis and management of diverticular disease of the colon in adults.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
    April 20, 2015 - Diagnostic Evaluation and Detection of Disease All solid renal masses and cystic lesions with solid … Patients with surgical chronic kidney disease (defined as chronic kidney disease as a result of surgical … resulting from medical renal disease. … syndromes and predictors of advanced/metastatic disease (e.g. … Mullins, J.K., et al., Tumor complexity predicts malignant disease for small renal masses.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
    May 29, 2025 - review to compare percutaneous coronary intervention with coronary artery bypass graft for coronary disease … Panel has raised concerns that these 23 trials enrolled patients with a relatively narrow spectrum of disease … (CER) to compare percutaneous coronary intervention with coronary artery bypass graft for coronary disease … Panel has raised concerns that these 23 trials enrolled patients with a relatively narrow spectrum of disease
  9. effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
    May 29, 2025 - review to compare percutaneous coronary intervention with coronary artery bypass graft for coronary disease … Panel has raised concerns that these 23 trials enrolled patients with a relatively narrow spectrum of disease … (CER) to compare percutaneous coronary intervention with coronary artery bypass graft for coronary disease … Panel has raised concerns that these 23 trials enrolled patients with a relatively narrow spectrum of disease
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diagnostic-tests-accuracy_research.pdf
    January 01, 2013 - Notation for observed counts and estimated probabilities in those with disease (D) and without disease … and individuals without disease). … and those without disease). … ) in study k Test Results Disease No Disease Negative (–) π D D k , 0 π k , 0 Positive (+) … ) and without disease (D ) in study k Test Results Disease, Counts Disease, Estimated Probabilities
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
    August 01, 2014 - ; CHD = coronary heart disease; CKD = chronic kidney disease; ESRD = end-stage renal disease; KQ = Key … National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologic, and Hematologic … Diseases. … Plasma elimination of cardiac troponin I in end-stage renal disease. … Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American
  12. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 13: Pulmonary Disease … Healthcare Horizon Scanning System Potential High- Impact Interventions: Priority Area 13: Pulmonary Disease … ES-2 Pulmonary Disease, Including Asthma, Interventions ........................................... … Priority Area 13: Pulmonary Disease, Including Asthma Topic High-Impact Potential 1. * Ivacaftor … The experts deemed one topic as having potential for high impact—a new disease-modifying drug targeted
  13. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/biorepositories-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - biospecimens, and this knowledge is being used to conduct further research to better understand how diseases … , the biology of the disease. … data can enable longitudinal research studies to examine the biological and genetic risk factors for diseases … The majority of biorepositories focus on collecting material from patients diagnosed with specific diseases … , and treatment of a wide range of serious and life-threatening illnesses, including cancer, heart diseases
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
    March 01, 2009 - Initiators of conventional APMs also had a higher risk for death due to respiratory diseases, nervous … system diseases and other causes. … disease. … , respiratory diseases, nervous system and other causes (Table 3). … International classification of diseases 9th revision clinical modification.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-bias_methods.pdf
    July 01, 2012 - standard, defined as the best comparator test to diagnose the disease or health condition in question … Interpreters may consider test results to be positive more frequently in settings with higher diseaseDisease progression bias Occurs when the index test is performed an unusually long time before the … report is the true disease status); in this case, the disease status is verified in the AFFECTED relatives … Systematic review: family history in risk assessment for common diseases.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
    January 01, 2011 - )  PAH is a progressive and incurable disease with a variety of etiologies and a pathology that … Based on disease etiology and severity of the disease, the timing and optimal combinations of drug therapy
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
    December 20, 2018 - activity” – not exactly improved disease activity, improved disease control? … discovering, developing, and delivering innovative, transformational medicines for patients with serious diseases … Since we know that autoimmune diseases evolve as a continuum starting years before the first clinical … is treatment- naïve disease. … Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration.
  18. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Potential High-Impact Interventions Report Priority Area 04: Dementia (Including Alzheimer’s Disease … Scanning System Potential High- Impact Interventions: Priority Area 04: Dementia (Including Alzheimer’s Disease … Priority Area 04: Dementia (Including Alzheimer’s Disease) Topic High-Impact Potential 1. … Off-label intranasal insulin for treatment of Alzheimer’s disease No high-impact potential; archived … that treatments that safely increase insulin levels or insulin signaling efficiency might improve disease
  19. Santa_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/santa_eccs2012.pdf
    February 01, 2013 - Slide 7: Comparison of Heart Disease Screening  Tests  (1 of 2) • Began  with the grades used … Preventive Services Task  Force. • Built ratings of common coronary or vascular disease screening … tests. • Added new evidence, frequency/burden  of disease, cost, and application to other  diseases … rated  tests  underused   o Poorly  rated  tests  overused Slide 8: Comparison of Heart Disease … • These people significantly overestimated their risk for cardiovascular disease.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
    May 20, 2013 - For stage I, II, and III disease, surgical resection is the primary treatment. … Approximately 20% to 30% of patients develop recurrent disease. … Disease characteristics (e.g., tumor grade) iii. … Disease characteristics (e.g., tumor grade) iii. … colorectal cancer” as an inclusion criterion, colon cancer and rectal cancer are somewhat different diseases

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: